Fueled by federal mandates, the emergence of big data, aging populations, and the pervasiveness of chronic diseases, the global healthcare analytics market is expected to reach $20.8 billion by 2020, according to IQ4I Research & Consultancy.
“Few factors such as lack of skilled labor with analytical skills, lack of patient data confidentiality and transparency, functional gap between payers and providers, increase in governmental regulation, and reimbursement issues are hampering the market growth,” concludes the research firm.
Last year, North America accounted for the largest share of the healthcare analytics market with 58.5 percent and also registered the highest compound annual growth rate (CAGR) during the firm’s 2014-2020 forecast period. Regions such as Middle East and North/South African countries are also expected to grow at a strong CAGR during that timeframe.
“The majority of the growth is driven by the factors such as government funding, technological standards, rising healthcare awareness/standards, extending social health insurance, and medical tourism,” according to IQ4I.
The healthcare analytics market is “consolidated” with major vendors accounting for more than 80 percent of the market share, the firm finds. The top 10 companies in the healthcare analytics market—all U.S.-based corporations—are Cerner, McKesson, Epic, IBM, Optum, Oracle, Allscripts, MedeAnalytics, Truven Analytics, and Information Builders.
Boding well for these vendors is a
And, more than 90 percent of respondents—all members of the College of Healthcare Information Management Executives—indicated that analytics will be “extremely important” or “very important” to their organization within the next 1-3 years.
Originally published by Health Data Management.
